Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
456
datasets available to search
ShareScore release 0.9.0
Dataset results
456 results for “mesothelioma”
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT06037941. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov study NCT02399371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
ClinicalTrials.gov study NCT04162015. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab + Defactinib In Pleural Mesothelioma
ClinicalTrials.gov study NCT04201145. IPD Sharing: YES. Countries: 1. Publications: 0.
Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
ClinicalTrials.gov study NCT01592383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
ClinicalTrials.gov study NCT02568449. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib in People With Malignant Mesothelioma
ClinicalTrials.gov study NCT03531840. IPD Sharing: NO. Countries: 1. Publications: 0.
Studying the Clinical Trial Experiences of Patients With Mesothelioma
ClinicalTrials.gov study NCT05819580. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
ClinicalTrials.gov study NCT02959463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
ClinicalTrials.gov study NCT02004028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab and Cryoablation in People With Mesothelioma
ClinicalTrials.gov study NCT05071014. IPD Sharing: YES. Countries: 1. Publications: 0.
Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT01112293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT04158141. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT02672033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
ClinicalTrials.gov study NCT00604461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
ClinicalTrials.gov study NCT04577326. IPD Sharing: YES. Countries: 1. Publications: 0.
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
ClinicalTrials.gov study NCT03436732. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma
ClinicalTrials.gov study NCT03126630. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT03710876. IPD Sharing: NO. Countries: 9. Publications: 0.
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
ClinicalTrials.gov study NCT00295503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.